Neurobiology of disease · 2014
Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bernard-Marissal Nathalie, Sunyach Claire, Marissal Thomas, Raoul Cédric, Pettmann Brigitte
Аннотация
Although the precise signaling mechanisms underlying the vulnerability of some sub-populations of motoneurons in ALS remain unclear, critical factors such as metallo-proteinase 9 expression, neuronal activity and endoplasmic reticulum stress have been shown to be involved. In the context of SOD1(G93A) ALS mouse model, we previously showed that a two-fold decrease in calreticulin (CRT) is occurring in the vulnerable fast motoneurons. Here, we asked to which extent the decrease in CRT levels was causative to muscle denervation and/or motoneuron degeneration. Toward this goal, a hemizygous deletion of the crt gene in SOD1(G93A) mice was generated since the complete ablation of crt is embryonic lethal. We observed that SOD1(G93A);crt(+/-) mice display increased and earlier muscle weakness and muscle denervation compared to SOD1(G93A) mice. While CRT reduction in motoneurons leads to a strong upregulation of two factors important in motoneuron dysfunction, ER stress and mTOR activation, it does not aggravate motoneuron death. Our results underline a prevalent role for CRT levels in the early phase of muscle denervation and support CRT regulation as a potential therapeutic approach.
Предметные рубрики MeSH
Activating Transcription Factor 6Age FactorsAmyotrophic Lateral SclerosisAnimalsCalreticulinDisease Models, AnimalEukaryotic Initiation Factor-2Gene Expression RegulationMiceMice, TransgenicMotor NeuronsMuscle WeaknessMuscular DiseasesNerve DegenerationReceptors, CholinergicSpinal CordSuperoxide DismutaseTOR Serine-Threonine KinasesVesicular Acetylcholine Transport Proteins